Automated And Closed Cell Therapy Processing Systems Market to Grow with a CAGR of 9.10% through 2028
Rising investments, regulatory support, and expanding
clinical applications are expected to drive the Global Automated And Closed
Cell Therapy Processing Systems Market growth in the forecast period,
2024-2028.
According to TechSci Research report, “Automated
And Closed Cell Therapy Processing Systems Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2028”, the
Global Automated And Closed Cell Therapy Processing Systems Market stood at USD
910.65 million in 2022 and is anticipated to grow with a CAGR of 9.10% in the
forecast period, 2024-2028. This can be attributed to expanding clinical
applications. Cell therapies are no longer limited to a few niche applications.
They are increasingly being explored for a broader range of clinical
conditions. As the number of clinical trials and approved therapies continues
to grow, so does the demand for automated and closed cell therapy processing
systems. These systems enable the efficient and scalable production of diverse
cell therapy products, catering to a wide spectrum of medical needs.
Furthermore, collaborations and partnerships between
academic institutions, biotechnology companies, and healthcare providers are on
the rise. These collaborations facilitate knowledge sharing, resource pooling,
and accelerated development of cell therapy technologies. Expect to see more
joint ventures aimed at advancing automation in cell therapy manufacturing.
The global pharmaceutical industry has greatly
benefited from the integration of automation into cell therapy processing and
manufacturing systems. These systems play a crucial role in selecting,
isolating, modifying, and expanding cells as part of the manufacturing process
for cell therapies. In this intricate process, even a minor error can lead to
incorrect cell infusion. However, automated and enclosed cell therapy
processing methods significantly reduce the risk associated with the final
product. Automation in cell therapy processing also mitigates the risk of
contamination that can result from manual labor. By reducing the possibility of
errors during bioprocessing, automated and enclosed cell treatment processing
systems enhance the efficiency of cell operations.
The rising global prevalence of cancer has driven the
demand for automated and enclosed cell therapeutic processing systems.
According to the Global Cancer Observatory study, Europe saw an estimated 4.39
million new cancer cases in 2020. Fully automated cell therapy processing
systems are designed to enable robust processing for diseases that are often
considered incurable. Leading companies in the global market are contributing
to this expansion by offering advanced platforms for the cell therapy manufacturing
process. In recent years, there has been substantial growth in clinical trials
related to advanced therapies, which has led to an increased need for advanced
and automated technologies to achieve high throughput and yield. This is
because automated and enclosed systems offer superior cell handling
capabilities and minimize the potential for errors during bioprocessing.
The availability of a range of systems offering both
fully automated integrated workflow solutions and partial automation is
expected to drive adoption in this field. Additionally, these systems enable
continuous monitoring of controlled therapy processing, which is crucial for
the development of new therapeutic platforms. Furthermore, integrated
intelligent algorithms ensure high precision in the process. Market players are
actively involved in developing infrastructure to support the production of
automated systems. For example, in June 2021, Lonza and Cell Point announced
their collaboration to utilize the Cocoon platform for the development of
T-cell-based therapies, aiming to demonstrate a proof of concept for
Point-of-Care (POC) production to optimize supply chain operations. As
automated systems can also enhance analytical testing and facilitate quality
control, their acceptance is expected to grow during the forecast period.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Automated And Closed Cell Therapy Processing Systems Market.”
The Global Automated And Closed Cell Therapy
Processing Systems Market is segmented into workflow, type, scale, regional
distribution, and company.
Based on its workflow, the most substantial revenue
share in 2022 came from the expansion segment. This growth can largely be
attributed to the extensive range of products available within this segment.
Furthermore, the proliferation of partnerships among market players, aimed at
adopting and applying systems within this segment, has been a significant
driver of its expansion. As an example, Angiocrine Bioscience has successfully
integrated Terumo BCT's quantum cell expansion system to expedite its cell therapy
research efforts.
Moving forward, it is anticipated that the separation
segment will exhibit the highest CAGR during the forecast period. The cell
separation process plays a pivotal role in various cellular experiments,
including molecular analysis, cellular genetic modification, hybridoma
production, and other cell research and analysis-related applications. The
growth in this segment is expected to be bolstered by the increasing number of
research activities in academic universities and other research settings for
these applications.
Based on scale, the pre-commercial/R&D scale
segment captured the largest share of revenue in the market in 2022. Currently,
this market segment is relatively small because there are only a limited number
of products available. Additionally, most companies are introducing their
products primarily for research purposes. For example, Cellares Inc., a cell
therapy manufacturing company, is planning to launch its automated cell therapy
machine in 2023. These factors are expected to stimulate the growth of the pre-commercial/R&D
scale segment throughout the forecast period. Furthermore, the increasing
adoption of automated systems by research institutes, driven by the growing
number of clinical trials for cell therapies, is also anticipated to accelerate
the growth of this segment.
Laboratories and research institutes are reaping
various benefits from the adoption of automated systems. According to a recent
study published by the National Center for Biotechnology Information (NCBI),
automated systems contribute to achieving high-speed processing and ensuring
the reliability of data. On the other hand, the commercial-scale segment is
projected to exhibit the fastest Compound Annual Growth Rate (CAGR) during the
forecast period. The rising prevalence of chronic conditions, such as cancer,
is motivating companies to develop advanced cell-therapy-based therapeutic
platforms.
Major companies operating in Global Automated And
Closed Cell Therapy Processing Systems Market are:
- Miltenyi Biotec Inc
- Lonza Group AG
- Fresenius Kabi AG
- Cytiva Europe GmbH
- Biospherix Ltd
- Terumo Corp
- Sartorius AG
- ThermoGenesis Holdings Inc
- Cellares Corporation
- Thermo Fisher Scientific Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global automated and closed cell therapy
processing systems market is on the brink of transformative change, with the
key trends driving innovation, efficiency, and safety. AI and machine learning,
miniaturization, advanced sensors, closed systems, single-use bioreactors,
decentralized manufacturing, personalized medicine, collaborations, and
regulatory advancements are all poised to shape the future of this dynamic
industry. As these trends continue to unfold, the potential for life-changing
cell therapies to reach patients around the world grows ever closer, promising
a brighter future for healthcare,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Automated And Closed Cell Therapy Processing
Systems Market By
Workflow (Separation, Expansion, Apheresis,
Fill-Finish, Cryopreservation, Others), By Type (Stem Cell Therapy, Non-Stem
Cell Therapy), By Scale (Pre-commercial/ R&D Scale, Commercial Scale), By Region, By Competition Forecast &
Opportunities, 2018-2028F”, has evaluated the future growth potential of Global
Automated And Closed Cell Therapy Processing Systems Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Automated And Closed Cell Therapy
Processing Systems Market.
Contact
Mr. Ken Mathews
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com